Par Pharmaceutical to Host Analyst Day on January 6, 2012
WOODCLIFF LAKE, N.J., Dec. 5, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) will hold an Analyst Day from 9:00am to 12:00pm EST on Friday, January 6, 2012 at the Millennium Hotel, 145 West 44th Street, New York City. Chairman and Chief Executive Officer, Patrick G. LePore, and other members of the senior management team will present an overview of the company's growth strategy, current products and pipelines, and business outlook to analysts and investors. This event will be webcast live on Par's website at www.parpharm.com or http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=81806&eventID=4251089 beginning at 9:00am. An archive of the webcast will be available within three hours of the conclusion of the event and can be viewed at the same link.
About Par Pharmaceutical Companies, Inc.
Par Pharmaceutical Companies, Inc. is a U.S.-based specialty pharmaceutical company. Through its wholly owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press releases and other company information, visit http://www.parpharm.com
SOURCE Par Pharmaceutical Companies, Inc.